SPI Pharma offers excipients, including effervescent powders, fructose and maltose powders, liquid sorbitol, lubricants, mannitol, sorbitol, and specialty binders/buffers. It also offers antacid actives, such as coblend suspension products, DC powders, aluminum hydroxide dried gels, magnesium hydroxide pastes, magnesium hydroxide powders, and vaccine support products; and drug delivery systems and solutions. SPI Pharma offers its products for application in solid dosage formulation, viscous suspensions/blends, DC chewing gum, effervescent systems, chewable/quick-dissolve tablets, and customized granulations. It sells its products through distributors in Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company also engages in the distribution of pharmaceutical, veterinary, nutraceutical, and food ingredients to customers in Australia. SPI Pharma, Inc. was formerly known as SPCA Barcroft. SPI Pharma was founded in 1930 and is based in Wilmington, Delaware.